Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Atricure Inc (ATRC)

Atricure Inc (ATRC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Atricure Inc 7555 INNOVATION WAY MASON OH 45040 USA

www.atricure.com Employees: 1,200 P: 513-755-4100 F: 888-347-6403

Description:

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.

Key Statistics

Overview:

Market Capitalization, $K 1,633,713
Enterprise Value, $K 1,612,523
Shares Outstanding, K 48,753
Annual Sales, $ 399,250 K
Annual Net Income, $ -30,440 K
Last Quarter Sales, $ 116,270 K
Last Quarter Net Income, $ -8,010 K
EBIT, $ -34,850 K
EBITDA, $ -18,920 K
60-Month Beta 1.40
% of Insider Shareholders 3.20%
% of Institutional Shareholders 99.11%
Float, K 47,193
% Float 96.80%
Short Volume Ratio 0.44

Growth:

1-Year Return -4.28%
3-Year Return -61.54%
5-Year Return 19.49%
5-Year Revenue Growth 98.01%
5-Year Earnings Growth 20.21%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.17 on 10/29/24
Next Earnings Date N/A
Earnings Per Share ttm -0.83
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 15.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ATRC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -8.12%
Return-on-Assets % -6.21%
Profit Margin % -7.62%
Debt/Equity 0.13
Price/Sales 4.05
Price/Cash Flow N/A
Price/Book 3.48
Book Value/Share 9.49
Interest Coverage -3.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar